Moreover, since CDC6 consistently yielded positive results in previous proliferation and migration assays, it suggests that CDC6 is a key downstream factor in the promotion of pancreatic cancer progression by the PVT1-MYC duet. This evidence concerns the gene MYC and familial pancreatic carcinoma.